Feds Want Labels On Antidepressant Suicide Risk

With all the Jewish neo-con cabal "we invaded Iraq for Israel" conspiracy bullshit they've been spewing in the past year, I pretty much don't read Adbusters anymore. This is in no small part due to the fact that, after I told Kalle Lasn he was being a cock in a letter to the editor, I haven't received another copy of the magazine, even though I already paid for it (I've been a Friend of the Foundation subscriber for three years).

But I digress. Marxist-antisemites as they may be, one thing that Adbusters has done, which I have always appreciated, is putting the spotlight on antidepressant drugs, specifically with their project Prozac Spotlight. The aim of Prozac Spotlight is to draw attention to the fact that antidepressants have a tendency to increase the risk of suicide in new patients, particularly youngsters — a fact which big drug companies like Eli Lily have been covering up, while greasing doctor's palms to get them to prescribe it.

Well, after over four years of shouting about it, the FDA is finally doing something — albeit meager in compared to what should be done, which is to pull the drugs off the shelves. The FDA has, instead,

ordered that all antidepressants carry "black box" warnings that they "increase the risk of suicidal thinking and behavior" in children who take them.

Welp, it ain't justice, but it's a start.